← FDA Drug Approvals (Drugs@FDA)
AMLODIPINE AND OLMESARTAN MEDOXOMIL
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: GLENMARK PHARMS LTD · Approved 2017-07-05
Drug application
- FDA Application #
ANDA207807- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- AMLODIPINE AND OLMESARTAN MEDOXOMIL
- Generic name
- AMLODIPINE AND OLMESARTAN MEDOXOMIL
- Active ingredients
- AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- GLENMARK PHARMS LTD
- Manufacturer
- Glenmark Pharmaceuticals Inc., USA
- First approval
- 2017-07-05
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown